INC Research Expands in Japan

INC Research is expanding and relocating its Tokyo, Japan office to support the company’s growth strategy in Japan and across the Asia/Pacific region. The new Tokyo location is 16,273 sq.-ft. and provides easy access to several train lines and nearby airports. The company outgrew its Tokyo offices as a result of quadrupling the number of employees in the past two years. The new office will support expansion of INC’s presence in Japan and the Asia/Pacific region, enabling the company to better accommodate its global drug development customers in the region. "Our continued expansion in Tokyo demonstrates our commitment to becoming the global ‘CRO of Choice’ within this vibrant pharmaceutical market for regional and global clinical trials," said Miranda Porter, Ph.D., senior vice president, Clinical Development, Tokyo. "Our employees provide global expertise within our therapeutically aligned delivery model while providing local experience and knowledge of Japan’s regulatory, healthcare and cultural environments. Our continued expansion in the country is making a strong contribution to INC’s overall growth."